share_log

Biodexa Pharmaceuticals | 6-K: Report of foreign private issuer (related to financial reporting)

SEC ·  May 16 05:01
Summary by Futu AI
Biodexa Pharmaceuticals PLC has announced the distribution of its Annual Report for the fiscal year ending December 31, 2023, along with the Notice of Annual General Meeting (AGM) to its shareholders. The announcement, made on May 15, 2024, includes the provision of proxy forms for both ordinary shareholders and holders of American Depositary Shares to participate in the upcoming AGM. The meeting is scheduled for June 13, 2024, at the company's registered office in Cardiff, United Kingdom. The documents related to the Annual Report and AGM, including proxy forms, have been attached as exhibits to the company's Form 6-K filing with the United States Securities and Exchange Commission for May 2024.
Biodexa Pharmaceuticals PLC has announced the distribution of its Annual Report for the fiscal year ending December 31, 2023, along with the Notice of Annual General Meeting (AGM) to its shareholders. The announcement, made on May 15, 2024, includes the provision of proxy forms for both ordinary shareholders and holders of American Depositary Shares to participate in the upcoming AGM. The meeting is scheduled for June 13, 2024, at the company's registered office in Cardiff, United Kingdom. The documents related to the Annual Report and AGM, including proxy forms, have been attached as exhibits to the company's Form 6-K filing with the United States Securities and Exchange Commission for May 2024.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Doc 2

Doc 3

Doc 4

Doc 5

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.